Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 82041000001119 | Angiotensin II acetate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 92431000001117 | Angiotensin II acetate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Angiotensin II acetate | Is a | Substance with receptor agonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Angiotensin II 2.5mg/1ml solution for infusion vials | Has specific active ingredient | True | Angiotensin II acetate | Inferred relationship | Existential restriction modifier | |
| Giapreza 2.5mg/1ml concentrate for solution for infusion vials (PAION Netherlands B.V.) | Has specific active ingredient | True | Angiotensin II acetate | Inferred relationship | Existential restriction modifier | |
| Angiotensin II 2.5mg/1ml solution for infusion vials 10 vial | Has specific active ingredient | True | Angiotensin II acetate | Inferred relationship | Existential restriction modifier | |
| Giapreza 2.5mg/1ml concentrate for solution for infusion vials (PAION Netherlands B.V.) 10 vial | Has specific active ingredient | True | Angiotensin II acetate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR